APYX stock icon

Apyx Medical


Market Cap: 47.8M


About: Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Employees: 252

Funds holding %
of 6,702 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

47,800% more call options, than puts

Call options by funds: $479K | Put options by funds: $1K

12.57% less ownership

Funds ownership: 50.28% [Q4 2023] → 37.71% (-12.57%) [Q1 2024]

18% less funds holding

Funds holding: 61 [Q4 2023] → 50 (-11) [Q1 2024]

50% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 20

61% less capital invested

Capital invested by funds: $45.6M [Q4 2023] → $17.8M (-$27.9M) [Q1 2024]

79% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 14

Research analyst outlook

We haven’t received any recent analyst ratings for APYX.

Financial journalist opinion